Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.12

-2.1%

Jan 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mlkr who wrote (2924)	6/11/2010 5:55:04 PM
From: Jibacoa	Read Replies (1) of 3722

Yes, KERX is bouncing up for 2nd day on a roll.<g> It has closed its small UG of April 12. ( Its larger one on Apr5 was almost completely closed the following day.) bigcharts.marketwatch.com It closed today above the resistance at the $4 level and near its intraday H. It was up 3.83% on good volume, but still about 0.4x its ADV. The L in the 1stQ was $4.0M ($0.07/shr) vs. $0.5M ($0.01/shr) on the black in 2009. In 2009 the results were helped by a $3M milestone payment from our Japanese partners, and the loss for 2010, includes $0.6M sof non-cash compensation expenes. At the end of the Q KERX reportedly had $32.1M in cash vs. $35.9M in 2009 and it received about $2.7M after the close of the Q from the exercise of options and warrants. KERX has two compounds that are currently in three PIIIs and claims to have sufficient capital to reach the proposed milestones. On Tuesday it reported results for its KRX-0401 in the treatment of advanced, metastatic colorectal Cas, at a poster at the ASCO meeting. The results were good as you mentioned, with 60% improvement in the over all survival rate and a more than double increase in the time to progression, which was the primary objective.<g> The ACTAY is $7.75 The stock is not off from its medium term DT coming from the May 4 H at $6.67 and has now a good amount of resistance at $5.35 before trying again the $6 level. But as mentioned, KERX seems to have enough resources to reach its milestone goals and the results of KRX-0401 look good. KERX has also the support from Roche and recent comments on TWST have been favorable. I know also know from previous comments that Tom Pope likes it.<g> With further good news it seems the stock could get to the $8 level for an almost 100% gain from present levels.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next